Indian Firms In Hot Chase To Market Generic Sovaldi
This article was originally published in PharmAsia News
Executive Summary
In a span of less than two weeks, at least five Indian drug makers have announced the introduction of their cut price versions of generic Sovaldi in the market. As the race is set to intensify further in the coming months, experts believe the most notable gains will accrue to those who get their pricing right, have a wide marketing footprint and devise market-building strategies to connect with untreated patients.